Yeah it does, well the market has certainly factored the EBITDA of $22m - $27m loss. Or could this be an excuse to buy back cheap?
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game